← FDA Drug Approvals (Drugs@FDA)

AMPICILLIN AND SULBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ONESOURCE SPECIALTY · Approved 2014-04-07

Drug application

FDA Application #

ANDA201024

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMPICILLIN AND SULBACTAM

Generic name

AMPICILLIN SODIUM, SULBACTAM SODIUM

Active ingredients

AMPICILLIN SODIUM; SULBACTAM SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ONESOURCE SPECIALTY

Manufacturer

Armas Pharmaceuticals Inc.

First approval

2014-04-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown